Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_assertion type Assertion NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_head.
- NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_assertion description "[Around 20% of breast cancers (BC) show ERBB2 gene amplification and overexpression of the ERBB2 tyrosine kinase receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_provenance.
- NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_assertion evidence source_evidence_literature NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_provenance.
- NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_assertion SIO_000772 20932292 NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_provenance.
- NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_assertion wasDerivedFrom befree-20150227 NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_provenance.
- NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_assertion wasGeneratedBy ECO_0000203 NP599689.RANyp8qLaEI9JaxmI4XFH5muEAr0YjGj-YTbDv5ApXLqk130_provenance.